Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor for HSC mobilization in pediatric solid tumors
NCT01288573Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of plerixafor in Ewing sarcoma, soft tissue sarcoma (STS), neuroblastoma, brain tumor, sponsored by Sanofi. Started Mar 2014; status: completed.
02
Drugs
plerixafor
03
Conditions
Ewing sarcomasoft tissue sarcoma (STS)neuroblastomabrain tumor
Beyond the preview
Go deeper on NCT01288573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288573.